# References

Bennett, P. and Calman, K. (eds) (1999) Risk Communication and Public Health, Oxford, Oxford University Press.

Courthauld, C. (2003) ‘The Critics’, The Observer on Sunday, 21 December.

Deer, B. (2004) ‘The truth behind the crisis’, Sunday Times, London, February 22.

Fitzpatrick, M. (2004) MMR and Autism: What Parents Need to Know, London, Routledge.

Gore, P., Madhavan, S., Curry, D., McClung, G., Castiglia, M., Rosenbluth, S.A. and Smego, R.A. (1999) ‘Predictors of childhood immunisation completion in a rural population’, Social Science & Medicine, 48, pp. 1011–27.

Horton, R. (2004) MMR: Science and Fiction – Exploring a Vaccine Crisis, London, Granta Books.

Miller, E., Andrews, N., Waight, P., Taylor, B. (2003) ‘Bacterial infections, immune overload, and MMR vaccine’, Archives of Disease in Childhood, 88, pp. 222–23.

Offit, P.A., Quarles, J., Gerber, M.A. et al. (2002) ‘Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?’ Pediatrics, 109, pp. 124–29.

Pattison, S. (2001) ‘Dealing with uncertainty’, British Medical Journal, 323, p. 840.

Scottish Executive (2002) Report of the Expert Group established by the Scottish Executive in response to recommendations set out in the Health and Community Care Committee's Report of the inquiry into issues surrounding the alleged relationship between the combined measles, mumps and rubella vaccine and autism [online]. Available from Scotland library [Accessed 12 March 2008].

Shaw, J. and Baker, M. (2004) ‘Expert patient – dream or nightmare?’, British Medical Journal, 328, pp. 723–24.

Wakefield, A.J. (1998) ‘Autism, inflammatory bowel disease, and MMR vaccine’ (correspondence: author's reply), Lancet, 363, pp. 823–24.

Wakefield, A.J., Murch, S.M., Anthony, A. et al. (1998) ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’, Lancet, 351, pp. 637–41.

Wing, L. and Potter, D. (2002) ‘The epidemiology of autistic spectrum disorders: is the prevalence rising?’, Mental Retardation and Development Disabilities Research Reviews, 8(3), pp. 151–61.

OpenLearn - The MMR vaccine: Public health, private fears
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.